欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FI/H/0969/001
药品名称Bortezomib MSN
活性成分
    • BORTEZOMIB 3.5 mg
剂型Powder for solution for injection
上市许可持有人Vivanta Generics s.r.o. Trtinova 260/1 19600 CAKOVICE, Czech Republic
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • Ireland (IE)
    • Netherlands (NL)
    • Poland (PL)
      Bortezomib MSN
    • Hungary (HU)
      BORTEZOMIB MSN 3,5 mg por oldatos injekcióhoz
    • Czechia (CZ)
      Bortezomib MSN
    • Romania (RO)
      Bortezomib MSN 3,5 mg pulbere pentru soluţie injectabilă
许可日期2018/09/19
最近更新日期2024/03/11
药物ATC编码
    • L01XX32 bortezomib
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase